"Slagelse Sygehus er et af fire sygehuse i Region Sjælland, som har en akutafdeling, der er specialiseret i hurtig behandling af akut opstående sygdomme."

During the past decade, Slagelse Hospital conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 3 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 1 clinical trials were completed. i.e. 5.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Slagelse Hospital" #1 sponsor was "Slagelse Hospital" with 5 trials, followed by "Herlev Hospital" with 3 trials sponsored, "Naestved Hospital" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Scandinavian Critical Care Trials Group" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Slagelse Hospital" #1 collaborator was "Rigshospitalet, Denmark" with 6 trials as a collaborator, "Holbaek Sygehus" with 5 trials as a collaborator, "Zealand University Hospital" with 5 trials as a collaborator, "Aarhus University Hospital" with 4 trials as a collaborator and "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 4 trials as a collaborator. Other collaborators include 76 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Slagelse Hospital" are "Septic Shock" (3 trials), "Aortic Aneurysm, Abdominal" (2 trials), "Arterial Occlusive Diseases" (2 trials), "Atherosclerotic Cardiovascular Disease" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Slagelse Hospital" in a lesser frequency.

Most popular intervention types in "Slagelse Hospital" are "Drug" (12 trials), "Other" (6 trials), "Biological" (4 trials), "Procedure" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "6% Hydroxyethyl starch 130/0.4" (1 trials), "Arthroplasty" (1 trials) and "Arthroscopic partial meniscectomy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Slagelse Hospital" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Slagelse Hospital". 1 are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Slagelse Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Slagelse Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 11 trials that are defined as “Not Applicable".